| CPC A61K 39/0008 (2013.01) [A61K 39/001 (2013.01); A61K 39/35 (2013.01); A61K 2039/6087 (2013.01); A61K 2039/6093 (2013.01); A61K 2039/627 (2013.01)] | 20 Claims |
|
1. A method for inducing antigen-specific immune tolerance, the method comprising:
administering to a subject a compound comprising Formula 1:
![]() where:
m is an integer from 1 to 100;
X comprises an antigen or a tolerogenic portion thereof;
Y is of a linker moiety having a formula selected from the group consisting of:
![]() ![]() wherein:
n is an integer from 1 to 100;
q is an integer from 1 to 100;
k is an integer from 1 to 12;
i is an integer from 0 to 20;
v is an integer from 1 to 4;
R1 is selected from the group consisting of —CH2—, —(CH2)2—C(CH3)(CN)—, —(CH2)2—C(CH3)(CH3)—, —(CH2)2—CH(CH3)—, and —CH(CH3)—; and
Y′ is a random copolymer or block copolymer of W1 and W2, where W1 and W2 are as depicted below:
![]() wherein the number of repeat units of W1 is denoted as p and wherein p is an integer of at least 1;
wherein the number of repeat units of W2 is denoted as r and wherein r is an integer of at least 1;
where R9 is a direct bond, —C(O)—NH—(CH2)2—, or
—C(O)—NH—(CH2)2— (O—CH2—CH2)t—, where t is an integer from 1 to 5; and
where R10 is —CH2—CH2—OH; and
R2 is selected from the group consisting of:
![]() where Ar is a substituted or unsubstituted aromatic group, R3 is any carbon-containing linear or heterocyclic moiety, and R11 is hydrogen or an optionally substituted alkyl; and
Z is galactose, glucose, galactosamine, glucosamine, N-acetylgalactosamine, or N-acetylglucosamine.
|